GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Physiomics PYC.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.43p

+1.19%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

£941,222

FY2017FY2026

Net income

−£697,034

FY2017FY2026

Free cash flow

−£566,170

FY2017FY2026

Shareholders' equity

£523,977

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue£941,222£784,005£543,250£597,354£830,266£702,314£799,055£783,101£512,899£270,465
Gross profit−£797,204−£435,077−£677,430−£581,622−£429,007−£365,785−£177,148−£178,669−£257,238−£489,190
Research and development—————————£211,220
Operating income−£797,204−£457,791−£670,816−£573,733−£359,114−£337,040−£177,150−£201,495−£260,390−£489,190
Net income−£697,034−£415,254−£609,352−£477,257−£253,137−£215,827−£64,423−£104,040−£183,341−£400,526
Diluted earnings per share-0.00-0.00-0.30-0.00-0.00-0.00-0.00-0.00-0.00-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets£788,551£892,026£422,603£674,393£1.1m£1.3m£1.4m£694,287£818,231£415,175
Cash and short-term investments£418,635£461,242£191,072£416,592£687,674£1.0m£1.0m£405,366£571,869£209,752
Total liabilities£264,574£199,855£140,076£142,673£140,609£157,570£131,517£86,373£128,205£86,921
Debt——£3,825£7,354£14,262£43,528£7,698−£1,250−£68,440—
Shareholders' equity£523,977£692,171£282,527£531,720£974,807£1.2m£1.3m£607,914£690,026£328,254
Shares outstanding387m303m2m135m97m97m97m72m72m57m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−£561,741−£546,143−£548,133−£264,863−£349,251−£32,496−£115,691−£143,772−£169,797−£437,274
Capital spending−£4,429−£3,935−£17,310−£6,635−£9,370−£16,153−£5,094−£21,816−£2,326−£6,802
Free cash flow−£566,170−£550,078−£565,443−£271,498−£358,621−£48,649−£120,785−£165,588−£172,123−£444,076

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Revenue£443,222£498,000£455,005£329,000£188,561£382,000£259,353£338,000
Gross profit−£444,201−£357,000−£186,077−£274,000−£414,119−£236,000−£287,114−£295,000
Operating income−£444,201−£357,000−£183,791−£274,000−£434,816−£236,000−£287,110−£295,000
Net income−£396,034−£301,000−£184,254−£231,000−£403,352−£206,000−£245,257−£232,000
Diluted earnings per share-0.00-0.00-0.00-0.12-0.20-0.00-0.00-0.00
Total assets£788,551£558,000£892,026£524,000£422,603£793,000£674,393£961,000
Cash and short-term investments£418,635£257,000£461,242£269,000£191,072£380,000£416,592£498,000
Debt————£3,825£16,000£124,543£95,000
Shareholders' equity£523,977£393,000£692,171£418,000£282,527£672,000£531,720£762,000

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.4%6.0%12.2%
Operating income11.6%18.8%6.9%
Net income13.5%26.4%6.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin-71.4%-86.9%-74.7%-67.9%
Operating margin-72.7%-87.2%-72.7%-67.0%
Net margin-64.5%-76.7%-60.7%-53.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-2.3-2.1-0.0-2.5-3.0-7.7-29.9-6.5-4.0-3.1
Price to sales1.71.10.02.00.92.42.40.91.44.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 19 Dec 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.